ALP
AlphaTON Capital Corp.
NASDAQ · Healthcare · Biotechnology · VG
$4.65
+3.33%7
Insider buys (3m)
0
Insider sells (3m)
$191.2K
Net value (3m)
-66.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | Villani Fiorenzo · director, officer: See Remarks | Purchase | 7,900 | $4.15 |
| Sep 17, 2026 | Villani Fiorenzo · director, officer: See Remarks | Purchase | 2,000 | $4.16 |
| Sep 17, 2026 | Villani Fiorenzo · director, officer: See Remarks | Purchase | 10,382 | $4.07 |
| Sep 17, 2026 | Villani Fiorenzo · director, officer: See Remarks | Purchase | 4,265 | $4.05 |
| Sep 14, 2026 | Villani Fiorenzo · director, officer: See Remarks | A-Award | 10,906 | $1.30 |
| Sep 14, 2026 | Kaiser Brittany · director, officer: Chief Executive Officer | A-Award | 7,416 | $0.00 |
| Sep 14, 2026 | Kaiser Brittany · director, officer: Chief Executive Officer | A-Award | 10,906 | $1.30 |
| Sep 14, 2026 | Kaiser Brittany · director, officer: Chief Executive Officer | Purchase | 9,350 | $5.35 |
| Sep 14, 2026 | Villani Fiorenzo · director, officer: See Remarks | A-Award | 12,359 | $0.00 |
| Sep 14, 2026 | Villani Fiorenzo · director, officer: See Remarks | A-Award | 11,735 | $0.00 |
| Sep 14, 2026 | Villani Fiorenzo · director, officer: See Remarks | Purchase | 7,000 | $5.07 |
| Sep 11, 2026 | Levitt Wesley Allen · officer: Chief Financial Officer | Purchase | 1,000 | $5.10 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 17, 2026